(Circulation. 2000;102:2082.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Heart Center, Department of Cardiology, University of Leipzig, Leipzig, Germany.
Correspondence to Hans Kottkamp, MD, University of Leipzig, Heart Center, Cardiology, Russenstrasse 19, D-04289 Leipzig, Germany. E-mail Kotth{at}medizin.uni-leipzig.de
| Abstract |
|---|
|
|
|---|
Methods and ResultsA total of 50 patients (mean age, 58±11 years) with typical atrial flutter were prospectively randomized to receive isthmus ablation using conventional fluoroscopy for catheter navigation (group I, n=24) or electromagnetic mapping (group II, n=26). Complete bidirectional isthmus block was verified with double potential mapping. If complete isthmus block could not be achieved after 20 radiofrequency pulses or 25 minutes of fluoroscopy, the patients were switched to the other group. Eight patients from group I (33%) but only 1 patient from group II (4%) were switched. Overall, complete isthmus block was achieved in 47 of 50 patients (94%). The overall fluoroscopy time, including the placement of the diagnostic catheters, was 22.0±6.3 minutes in group I and 3.9±1.5 minutes in group II (P<0.0001). The fluoroscopy time needed for isthmus mapping was 17.7±6.5 minutes in group I and 0.2±0.3 minutes in group II (P<0.0001).
ConclusionsElectromagnetic mapping during the induction of linear lesions for the ablation of atrial flutter permitted a highly significant reduction in exposure to fluoroscopy while maintaining high efficacy, and it allowed the time required for fluoroscopy to be reduced to levels anticipated for diagnostic electrophysiological studies.
Key Words: catheter ablation arrhythmia atrial flutter electrophysiology mapping
| Introduction |
|---|
|
|
|---|
Recently, a novel method for electromagnetic catheter-based nonfluoroscopic mapping of the heart was introduced.16 Experimental and first clinical studies indicated that the results obtained using this system were accurate and reproducible.17 18 19 This electromagnetic system might be especially useful for mapping an anatomically defined target area (ie, the inferior isthmus). In the present clinical study, the impact of electromagnetic isthmus mapping on total fluoroscopy exposure was compared with conventional fluoroscopic mapping in patients with typical atrial flutter in a prospective, randomized fashion.
| Methods |
|---|
|
|
|---|
|
RF Catheter Ablation
The electrophysiological study and
ablation were performed with the patients in a fasting, nonsedated
state, after having obtained written, informed consent. In all
patients, multipolar electrode catheters were placed in the right
ventricular apex and proximal coronary sinus under
fluoroscopic guidance. Mapping the myocardial isthmus between the
inferior aspect of the TA and the ICV was performed during
pacing in the proximal coronary sinus with cycle lengths of 500
to 600 ms. In patients with sustained atrial flutter at the beginning
of the mapping procedure, terminating the arrhythmia was done
using multiple extrastimuli or high-rate overdrive pacing to restore
sinus rhythm.
All patients were randomly assigned to undergo isthmus ablation with conventional fluoroscopic isthmus mapping (group I, n=24) or electromagnetic (Carto, BiosenseWebster) isthmus mapping (group II, n=26). In both groups, RF energy was delivered sequentially with the 4-mm tip electrode of a deflectable 7-French catheter (Navistar, BiosenseWebster). The preselected temperature at the tip of the catheter was 60°C to 70°C, and the pulse duration was 60 to 90 seconds. The ablation catheter was not withdrawn during the individual applications of energy. Complete bidirectional isthmus conduction block was verified with double-potential mapping during pacing from both sides of the lesion line.14 If complete isthmus block could not be achieved after 20 RF pulses or 25 minutes of fluoroscopy, the patients were switched to the other group.
Electromagnetic System
The electromagnetic mapping system consists of an external,
ultralow emitter of a magnetic field, a set of 2 catheters with
miniature magnetic field sensors, and a processing computer unit
(Carto, BiosenseWebster).16 17
Electromagnetic Mapping
The ablation catheter was advanced into the right atrium under
fluoroscopic guidance, and one specific point was acquired at the most
inferior point of the TA. At that site, a small atrial
potential and a larger ventricular potential were
recorded. After having acquired this point, the mapping procedure
was continued using the electromagnetic mapping system without
fluoroscopy. The catheter was then slightly rotated to 2 additional
points at the TA, 1.5 to 2 cm septally and laterally, respectively
(Figures 1
and 2
). Three points were then acquired at
the mouth of the ICV: one was directly opposite to the
inferior point of the TA, and the other 2 points were
slightly lateral and medial (Figure 2
). The 3 points at the TA were
tagged with green dots, and the 3 points at the ICV with pink dots. In
this way, the individual myocardial isthmus extension was clearly
defined and could be depicted in the 3D space ("6-point
reconstruction"). The sites of all RF pulses were annotated on the
electroanatomical isthmus map (Figure 2
). The "bottom" view
(strictly caudal projection) was mainly used to manipulate the
ablation catheter because lateral or septal displacement can be judged,
as can the distance from the TA and ICV (Figures 1
and 2
). Additional projections, like the right anterior oblique
view, were used if necessary.
|
|
After inducing the first line of lesions, the isthmus was remapped to control for double potentials and conduction times. In cases of incomplete lesion lines, the ablation catheter was renavigated for precise localization of gaps, and RF energy was then specifically applied to the identified gaps.
Fluoroscopic Mapping
In the conventional fluoroscopic group, biplane fluoroscopy with
right anterior oblique and left anterior oblique projections was
used for orientation and manipulation of the ablation catheter during
the mapping procedure. The fluoroscopy was continuous. During the
individual energy applications, fluoroscopy was used continuously only
when it was difficult to stabilize the ablation catheter. In cases of
energy application with stable catheter positions, fluoroscopy was only
used periodically to control catheter position.
After inducing the first line of lesions, the isthmus was remapped to control for double potentials and conduction times. In cases of incomplete lesion lines, gaps were identified and RF energy was then specifically applied to the identified gaps.
Follow-Up
After hospital discharge, follow-up assessment was performed
during periodic visits to the supervising cardiologist; assessments
included 12-lead ECG and 24-hour Holter monitoring. In the event of
atrial flutter recurrence, a repeat
electrophysiological study and ablation
were advised.
Statistical Analysis
Quantitative data were expressed as mean±SD. Statistical
comparisons were performed using the Students t test, Mann
Whitney U test, or
2 analysis as
appropriate. P<0.05 was considered statistically
significant.
| Results |
|---|
|
|
|---|
Fluoroscopy Times
The overall fluoroscopy time, including the placement of the
diagnostic catheters, was 22.0±6.3 minutes in group I and
3.9±1.5 minutes in group II (P<0.0001). The fluoroscopy
times needed for the placement of the diagnostic catheters
were not significantly different between groups I and II (4.3±1.6
versus 3.7±1.4 minutes; P=NS). The fluoroscopy time needed
for isthmus mapping was 17.7±6.5 minutes in group I and 0.2±0.3
minutes in group II (P<0.0001). In 16 patients from group
II (62%), the entire isthmus-mapping part of the ablation for typical
atrial flutter was performed nonfluoroscopically. Overall, total
fluoroscopy times and isthmus mapping fluoroscopy times were reduced in
the electromagnetic mapping group by 82.3% and 99%, respectively,
compared with conventional fluoroscopic mapping (Figure 3
).
|
RF Pulses and Procedure Times
The mean number of RF pulses needed to achieve complete isthmus
conduction block was 10±5 pulses (range, 2 to 21 pulses) in group I
and 8±4 pulses (range, 2 to 18 pulses) in group II (P=NS).
The overall procedure times, including placement of the
diagnostic catheters and a waiting period of 10 minutes for
identification of early recovery of isthmus conduction after the last
RF pulse, were 75.5±27.1 minutes in group I and 57.1±24.2 minutes in
group II (P<0.05).
Follow-Up
During a mean follow-up of 12±5 months, atrial flutter recurred
in 2 of the 47 patients (4.3%) with complete isthmus conduction block
after the ablation session and in 2 of the 3 patients (66.7%) with
only partial isthmus conduction block after the initial ablation
session.
| Discussion |
|---|
|
|
|---|
Fluoroscopy for Atrial Flutter Ablation
When using conventional RF ablation to cure typical atrial
flutter, fluoroscopy in 1 or 2 planes is used to orient and navigate
the catheter. In addition, fluoroscopy is often also used during the
delivery of individual bursts of energy, especially when it is
necessary to judge unstable or displaced positions of the catheter.
This may lead to substantial exposure to fluoroscopy during isthmus
ablation, even in experienced centers, with fluoroscopy times lasting
from 31±10 minutes to 114±45 minutes, even in recent
studies.10 13 20 21 22 23 24 It might be anticipated that
fluoroscopy exposure is even higher in low-volume centers.
In the present study, the overall fluoroscopy time, including the placement of the diagnostic catheters, was 22.0±6.3 minutes in group I (conventional fluoroscopic mapping) and 3.9±1.5 minutes in group II (electromagnetic mapping). However, 33% of the patients in group I switched to group II after 20 RF pulses or 25 minutes of fluoroscopy, and the ablation procedure was performed using the electromagnetic system. The highly significant difference in overall fluoroscopy exposure between the 2 groups in our study might thus be underestimated. In 62% of the patients in the electromagnetic mapping group, the entire isthmus-mapping part of the ablation for typical atrial flutter was performed nonfluoroscopically.
The positive significance of isthmus ablation in patients with atrial flutter on quality of life has recently been described.25 In addition, catheter ablation is curative in many patients, may obviate the need for life-long antiarrhythmic drug medication, and may be more cost effective in the long term than antiarrhythmic drug therapy. However, substantial fluoroscopy exposure, which is necessary for conventional isthmus ablation, carries the well-known inherent risks of radiation during long-term follow-up.15 Kovoor et al15 even concluded that the small risks of radiation-induced malignancy should be explained to patients undergoing procedures requiring prolonged fluoroscopy to ensure that they are fully informed of all potential risks. The significant reduction in radiation exposure that can be achieved with electromagnetic mapping for isthmus ablation in patients with atrial flutter may, therefore, have an impact on the long-term safety of this invasive treatment strategy.
New Developments in Isthmus Ablation
Jaïs et al26 described successful
irrigated-tip catheter ablation of atrial flutter that is
resistant to conventional RF catheter ablation. Although the
exact reason for resistance to conventional RF energy application is
unclear, it may be due to an unusually thick isthmus
myocardium; saline irrigation of the ablation electrode
produces larger and deeper lesions.27 Jaïs et
al28 recently described a randomized comparison of
irrigated-tip versus conventional-tip catheters for the ablation of
common flutter and reported a significant reduction in fluoroscopy time
with the irrigated-tip catheter (9±6 versus 18±14 minutes).
Alternatively, a larger, 8-mm tip electrode can achieve larger lesion
volumes compared with 4-mm tip electrodes; this may facilitate isthmus
ablation in patients with atrial flutter.29
Recently, Nakagawa and Jackman30 described their initial experience with using the electromagnetic mapping system to examine the global right atrial activation pattern in patients during atrial flutter. In their article, they concentrated on the methodological aspects of the electromagnetic system with respect to atrial flutter ablation.30 Shah et al31 performed high-density electromagnetic mapping of activation through an incomplete isthmus ablation line in 8 patients, with recurrence of atrial flutter after previous catheter ablation. In the present study, only the area between the inferior aspect of the TA and the corresponding border toward the ICV (target-area mapping) was performed, in contrast to mapping an entire cardiac chamber (eg, the right atrium). This allows a clinically oriented approach toward direct isthmus ablation in patients with typical atrial flutter.
Conclusions
In this prospective, randomized study, total fluoroscopy times and
isthmus mapping fluoroscopy times were reduced in the electromagnetic
mapping group by 82.3% and 99%, respectively, compared with
conventional fluoroscopic mapping in patients with typical atrial
flutter undergoing isthmus ablation. In addition, overall procedure
time was significantly shorter in the electromagnetic mapping group. A
substantial reduction in exposure to radiation by using electromagnetic
mapping may have an impact on the long-term safety of this invasive
procedure that has widespread clinical application.
Received April 13, 2000; revision received May 30, 2000; accepted June 8, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. Showkathali, M. J. Earley, D. Gupta, M. Alzetani, S. Harris, P. M. Kistler, S. C. Sporton, and R. J. Schilling Current case mix and results of catheter ablation of regular supraventricular tachycardia: are we giving unrealistic expectations to patients? Europace, November 1, 2007; 9(11): 1064 - 1068. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kirchhof, A. Auricchio, J. Bax, H. Crijns, J. Camm, H.-C. Diener, A. Goette, G. Hindricks, S. Hohnloser, L. Kappenberger, et al. Outcome parameters for trials in atrial fibrillation: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association Europace, November 1, 2007; 9(11): 1006 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Earley, R. Showkathali, M. Alzetani, P. M. Kistler, D. Gupta, D. J. Abrams, J. A. Horrocks, S. J. Harris, S. C. Sporton, and R. J. Schilling Radiofrequency ablation of arrhythmias guided by non-fluoroscopic catheter location: a prospective randomized trial Eur. Heart J., May 2, 2006; 27(10): 1223 - 1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Scavee, P. Jais, L.-F. Hsu, P. Sanders, M. Hocini, R. Weerasooriya, L. Macle, F. Raybaud, J. Clementy, and M. Haissaguerre Prospective randomised comparison of irrigated-tip and large-tip catheter ablation of cavotricuspid isthmus-dependent atrial flutter Eur. Heart J., June 1, 2004; 25(11): 963 - 969. [Abstract] [Full Text] [PDF] |
||||
![]() |
Committee Members, C. Blomstrom-Lundqvist, M. M. Scheinman, E. M. Aliot, J. S. Alpert, H. Calkins, A. J. Camm, W. B. Campbell, D. E. Haines, K. H. Kuck, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias --executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) Developed in Collaboration with NASPE-Heart Rhythm Society J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1493 - 1531. [Full Text] [PDF] |
||||
![]() |
C. Blomstrom-Lundqvist, M. M. Scheinman, E. M. Aliot, J. S. Alpert, H. Calkins, A. J. Camm, W. B. Campbell, D. E. Haines, K. H. Kuck, B. B. Lerman, et al. ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias*--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias) Circulation, October 14, 2003; 108(15): 1871 - 1909. [Full Text] [PDF] |
||||
![]() |
Committee Members, C. Blomstrom-Lundqvist, M. M Scheinman, E. M Aliot, J. S Alpert, H. Calkins, A.J. Camm, W.B. Campbell, D. E Haines, K. H Kuck, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: A Report of the American College of Cardiology/American HeartAssociation Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines(Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias)Developed in collaboration with NASPE-Heart Rhythm Society Eur. Heart J., October 2, 2003; 24(20): 1857 - 1897. [Full Text] [PDF] |
||||
![]() |
H. A. Kopelman, S. P. Prater, F. Tondato, N. A. F. Chronos, and N. S. Peters Slow pathway catheter ablation of atrioventricular nodal re-entrant tachycardia guided by electroanatomical mapping: a randomized comparison to the conventional approach Europace, January 1, 2003; 5(2): 171 - 174. [Abstract] [PDF] |
||||
![]() |
P. A Friedman Novel mapping techniques for cardiac electrophysiology Heart, June 1, 2002; 87(6): 575 - 582. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |